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presence of retinal vasculitis, hence oral and topical steroids were continued in the postoperative period. No exacerbation of MS symptoms occurred in 2 months follow-up.
Perioperative care in MS patients poses challenges because of variable neurological involvement, concurrent long-term immunosuppression treatment, and risk of disease exacerbation. The effects of different anesthetics and anesthesia regimen in terms of rapid awakening with intact cognitive domain and protective immunomodulation have been studied. [3, 4] We used propofol as induction agent that has neuronal protective effect and antioxidant action. [5] Rapid recovery, the benefit of propofol could be jeopardized following prolonged or high-dose infusion.
High levels of IL-6 (cytokine) were correlated with low Minimental State Examination scores in MS patients representing impaired cognitive domain. [2] Desflurane is known for rapid recovery and is associated with lesser rise in IL-6 levels. [3] We hypothesized that acute increase in the levels of inflammatory mediators like IL-6 is a possible common factor among all causes of acute exacerbations; hence, desflurane may offer added advantage in presence of appropriate management of other risk factors.
In conclusion, this case underlines the safety of general anesthesia with desflurane in MS patients and warrants carefully individualized perioperative management.
Financial support and sponsorship

Nil.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Late onset Pneumothorax following bronchoscopic foreign body removal
Sir, Foreign body impaction in the airway is a common cause of morbidity in children. Rigid bronchoscopy is considered the gold standard for tracheobronchial foreign body removal. Major life-threatening complications such as pneumothorax, pneumomediastinum, airway obstruction, cardiorespirator y arrest, arrhythmias and pulmonar y edema may occur. [1] A 15-month-old male child weighing 9 kg was posted for bronchoscopic foreign body removal. The child had 2 days history of increased respiratory distress. Preoperative examination revealed reduced air entry on the right side of the chest and oxygen saturation 99% on room air. Chest X-ray revealed a hyper-inflated right lung due to air trapping [ Figure 1 ]. Multislice computed tomography scan of chest revealed 8 mm × 5 mm sized soft tissue in right main bronchus approximately 1-1.2 cm from the carina obliterating the bronchial lumen resulting in air trapping in the entire right lung. After premedication with IV midazolam, anesthesia was induced with propofol and muscle relaxation was obtained with succinylcholine. Rigid bronchoscopy was performed by a senior bronchoscopist and child was ventilated through the ventilating port of the bronchoscope using Jackson Rees circuit. Anesthesia was maintained with intermittent doses of IV propofol. Foreign body consisting of bits of betel nut approximately 1 cm × 1 cm was removed piecemeal. Child was then intubated, and positive pressure ventilation was given. Suctioning and positional drainage of secretions were done in the right side up and head low position. Postextubation there was improved air entry on the right side of the chest.
Two hours postprocedure, the patient developed breathlessness and tachypnea. A chest X-ray was done which revealed a pneumothorax of approximately 20%
[ Figure 2 ]. Immediately a right sided intercostal drain (ICD) was inserted. Follow-up Chest X-ray revealed re-expansion of the right lung.
The pathophysiology of pneumothorax can be varied. Air trapping caused by the poststenotic bronchial obstruction increases the transpulmonary pressure gradient. Positive pressure ventilation may further increase the pressure gradient causing alveolar rupture. Air enters the interstitial tissues of the lung and pleural space resulting in pneumothorax. [2] A pneumothorax can occur during a transbronchial lung biopsy. A one-way valve mechanism develops because of transbronchial instrumentation leading to a rent allowing the air to enter the pleural cavity during positive pressure ventilation but not allowing it to leave during the expiratory phase. [3] Pneumothorax usually manifests itself during surgery or in the immediate postbronchoscopy period by a fall in oxygen saturation, a rapid increase in airway pressure, hypotension, and tachycardia. Symptoms and/or signs of a pneumothorax may be delayed but is uncommon. [4] Hence to conclude, pneumothorax postbronchoscopy can manifest as a delayed complication. Early diagnosis and prompt management are essential. Patients should be kept under continued observation anticipating this possibility. The British Thoracic society recommends that a chest X-ray should be obtained if a patient is symptomatic; if there is a clinical suspicion of possible pneumothorax after bronchoscopy and at least 1 h after transbronchial biopsy to exclude a pneumothorax. [5] Drainage of pneumothorax with ICD placement is life-saving and should be done immediately. 
Is a minimum dose of atropine in children justified?
Sir, Atropine, a parasympatholytic agent, has an important role in neonates and infants who respond to stimulation (laryngoscopy, intubation, and suctioning) primarily by bradycardia because of an immature sympathetic system. Recently, a term neonate, 2.5 kg, developed acute anticholinergic syndrome following intraoperative administration of three doses of 0.1 mg atropine to counter bradycardia. The reason for administering this dose was that 0.1 mg is the recommended minimum dose of atropine as a lower dose causes paradoxical bradycardia resulting from a central stimulating effect on the medullary vagal nuclei. Indeed, a literature search revealed references where the minimum dose is mentioned. [1] [2] [3] In Pediatric Advanced Life Support (PALS): 2010 American Heart Association Guidelines, "medications for pediatric resuscitation," the dose of atropine is stated as "0.02 mg/ kg intravenous/intraosseous and repeat once, if needed; minimum dose is 0.1 mg, maximum single dose is 0.5 mg." [1] In the text book of Miller's anesthesia, [2] the algorithm for bradycardia, in the limb describing "persistent symptomatic bradycardia -if vagal tone or primary AV block," it is recommended, "to give atropine, first dose: 0.02 mg/kg, and may repeat (minimum dose: 0.1 mg; maximum total dose for child: 1 mg)." The 8
th Edition of Smith's Anesthesia for Infants and Children [3] states that the pediatric dose for atropine is 0.02 mg/kg, with a minimum dose of 0.15 mg and a maximal dose of 2 mg. Again, Morgan and Mikhail's Clinical Anesthesiology mentions that "atropine (0.1 mg minimum) must always be administered before succinylcholine in children." In addition, Table 42 -3 pediatric drug dosages states "minimum dose −0.1 mg."
The dose for atropine is 0.02 mg/kg; therefore, the minimum dose recommendation affects infants with a body weight of <5 kg. Using the minimum dose recommendation, a 1 kg neonate would receive a 5-fold overdose of atropine. [4] In this regard, PALS references an article published by Dauchot and Gravenstein. [5] The authors studied the effects of atropine on the electrocardiogram in different age groups in 79 patients (6 weeks to 79 years). They demonstrated that very low doses of atropine (3.6 µg/kg or less) might cause a mild slowing of the heart rate. The source of the often-repeated minimum absolute dose of atropine is a statement in the discussion of this article [5] where the authors state "for preanaesthetic medication of a normal newborn baby, we prescribe 0.1 mg of atropine sulfate." It is to be noted that there were no neonates in this study; the youngest subjects (n = 5) were between 6 weeks and 3 years in whom the heart rate slowing effect was not statistically significant. The results of this study do not support this statement that has been quoted by other authors. Barrington has also questioned the myth of a minimum dose of atropine. [4] Atropine doses of 0.01 and 0.02 mg/kg have been successfully used with an increase in heart rate and prevention of laryngoscopy-induced bradycardia. The incorrect and potentially harmful recommendation of 0.1 mg minimum dose of atropine should be removed from the text to prevent overdose in infants <5 kg body weight.
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